A Lactation Study in Women Receiving Treatment With Ozanimod

PHASE4RecruitingINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

September 16, 2025

Primary Completion Date

December 16, 2026

Study Completion Date

December 16, 2026

Conditions
Lactating WomenBreastfed Infants
Interventions
DIAGNOSTIC_TEST

Breast milk, plasma, and blood samples

Although this study is non- interventional regarding treatment with ozanimod, the study is considered interventional due to the collection of breast milk and plasma from the lactating women and blood samples from their breastfed infants and the additional diagnostic and monitoring procedures required for the study.

Trial Locations (1)

89113-2228

RECRUITING

PPD Las Vegas Clinical Research Unit, Las Vegas

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY